Publications by authors named "G M J de Wit"
Purpose: The Teller Acuity Card (TAC) procedure is a preferential-looking method to assess visual acuity in infants and preverbal children and provides a quantitative measure of grating acuity. Several studies containing reference values have been published, the majority based on an older version of the TAC card set. In 2003, a new version of the TAC was released, called the TAC II.
View Article and Find Full Text PDFBackground: Low-value care is unnecessary care that contributes to inefficient use of health resources and constitutes a considerable proportion of healthcare expenditures worldwide. Factors contributing to patients' demand for low-value care have often been overlooked and are dispersed in the literature. Therefore, the current study aimed to systematically summarize factors associated with patients' demand for low-value care.
View Article and Find Full Text PDFArticle Synopsis
- This study examines how myopia (nearsightedness) progresses in children with congenital stationary night blindness (CSNB), a type of inherited retinal disorder, to better evaluate potential treatments.
- The researchers analyzed refraction measurements from 127 CSNB patients between ages 0 and 21, finding that myopia generally develops quickly in early childhood but stabilizes after age 4, with only slight progression thereafter.
- The findings suggest that children with CSNB have a stable refractive error after age 4, highlighting the need for tailored myopia control approaches for this specific group.
Purpose: To provide patients with MET-mutated advanced non-small cell lung cancer (METmut aNSCLC) access to crizotinib, further substantiate evidence of its efficacy and safety in this setting, and find potential biomarkers for nonresponse.
Patients And Methods: In the Drug Rediscovery Protocol (NCT0295234), patients with an actionable molecular profile are treated with off-label registered drugs. Both treated and untreated patients with aNSCLC harboring MET exon 14 skipping or other MET mutations received crizotinib 250 mg BID until disease progression or intolerable toxicity.
The smallest worthwhile effect (SWE) is the smallest beneficial effect of an intervention that justifies the costs, risks, and inconveniences. The objective is to establish the SWE of spinal manipulative therapy (SMT) for the treatment of low back pain (LBP), and to gain insight into how different attributes of the treatment are traded among each other when choosing SMT. Part 1.
View Article and Find Full Text PDF